Biogaia AB
STO:BIOG B
Biogaia AB
STO:BIOG B
Price:
106.4
SEK
-0.93%
Market Closed
Market Cap:
kr10.5B
Relative Value
The Relative Value of one
BIOG B
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 106.4 SEK,
Biogaia AB
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIOG B Relative Value
HIDDEN
Multiples Across Competitors
BIOG B Competitors Multiples
Biogaia AB Competitors
Biogaia AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Biogaia AB
STO:BIOG B
|
10.9B SEK | 7 | 32.3 | 22.8 | 24.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.9B USD | 6.8 | 172.1 | 16.6 | 23.6 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 377 | -2 377 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.6B USD | 5.6 | 26.5 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.5B USD | 10.2 | 31 | 23.7 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.7B USD | 5.8 | 18.4 | 13.9 | 15.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR | 14.2 | 33.5 | 57.5 | 59 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.7B AUD | 3.1 | 16.3 | 11.2 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
